Related references
Note: Only part of the references are listed.Anomalous collapses of Nares Strait ice arches leads to enhanced export of Arctic sea ice
G. W. K. Moore et al.
NATURE COMMUNICATIONS (2021)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
Covid-19: Germany struggles with slow uptake of Oxford AstraZeneca vaccine
Hristio Boytchev
BMJ-BRITISH MEDICAL JOURNAL (2021)
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Responding to Covid-19-A Once-in-a-Century Pandemic?
Bill Gates
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Molecular Characterization and Amino Acid Homology of Nucleocapsid (N) Protein in SARS-CoV-1, SARS-CoV-2, MERS-CoV, and Bat Coronavirus
Shantani Kannan et al.
JOURNAL OF PURE AND APPLIED MICROBIOLOGY (2020)
Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?
Luciano Mutti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Activating Immunity to Fight a Foe - A New Path
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy
Pierpaolo Correale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
ACE2 and COVID-19 and the resulting ARDS
Xiaoqing Zhang et al.
POSTGRADUATE MEDICAL JOURNAL (2020)
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency
Thamina Acter et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Misguided Use of Hydroxychloroquine for COVID-19 The Infusion of Politics Into Science
Michael S. Saag
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Drug targets for corona virus: A systematic review
Manisha Prajapat et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Guangyu Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Nanoparticle-Based Vaccines Against Respiratory Viruses
Soultan Al-Halifa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Detection and full genome characterization of two beta CoV viruses related to Middle East respiratory syndrome from bats in Italy
Ana Moreno et al.
VIROLOGY JOURNAL (2017)
Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus
S. J. Anthony et al.
MBIO (2017)
Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus
Ben Hu et al.
PLOS PATHOGENS (2017)
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
Akram Khan et al.
CRITICAL CARE (2017)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells
Lei Cui et al.
JOURNAL OF VIROLOGY (2015)
Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis
Jose L. Nieto-Torres et al.
PLOS PATHOGENS (2014)
MERS-Related Betacoronavirus in Vespertilio superans Bats, China
Li Yang et al.
EMERGING INFECTIOUS DISEASES (2014)
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study
Matthew Cotten et al.
LANCET (2013)
Human Betacoronavirus 2c EMC/2012-related Viruses in Bats, Ghana and Europe
Augustina Annan et al.
EMERGING INFECTIOUS DISEASES (2013)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Evidence for a Common Evolutionary Origin of Coronavirus Spike Protein Receptor-Binding Subunits
Fang Li
JOURNAL OF VIROLOGY (2012)
Identification of In Vivo-Interacting Domains of the Murine Coronavirus Nucleocapsid Protein
Kelley R. Hurst et al.
JOURNAL OF VIROLOGY (2009)
A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo
Marta L. DeDiego et al.
JOURNAL OF VIROLOGY (2007)
Architecture of the SARS coronavirus prefusion spike
Daniel R. Beniac et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex
Eric J. Snijder et al.
JOURNAL OF VIROLOGY (2006)
Modular organization of SARS coronavirus nucleocapsid protein
CK Chang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus
S Hussain et al.
JOURNAL OF VIROLOGY (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
SWISS-MODEL: an automated protein homology-modeling server
T Schwede et al.
NUCLEIC ACIDS RESEARCH (2003)
Share Paper
